CymaBay Therapeutics, Inc. CBAY
Set alert
32.48 0.00 0.00%
At close · Mar 21
32.48 Day range 32.50
52-week range unavailable
- Open
- 32.49
- Prev close
- 32.48
- Mkt cap
- 3.73B
- Vol
- 8.35M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 32.48
- High
- 32.50
- Forward P/E
- -30.93
- Beta
- 0.32
- Short ratio
- 0.84
- Inst. own
- 103.13%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 28, 2024
- 50-d avg
- 29.11
- 200-d avg
- 19.07
- 1y target
- 32.50
3M chart
Events in this range
- Feb 28, 2024Earnings: —; estimate -0.32; surprise —%
Signals (7)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Mar 1, 2024 | 2 years ago |
| RSI: Overbought | Feb 12, 2024 | 2 years ago |
| MACD: Buy Signal | Feb 8, 2024 | 2 years ago |
| SMA: Bullish | Jan 29, 2024 | 2 years ago |
| SMA: Bearish | Jan 24, 2024 | 2 years ago |
| RSI: Overbought | Jan 9, 2024 | 2 years ago |
| MACD: Sell Signal | Jan 3, 2024 | 2 years ago |
Financial health
Altman Z-Score
12.91 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -23.9×
FY 2014 5y median -4.6× FY 2023
P/S 80.7×
FY 2014 5y median 0.0× FY 2023
P/B 8.6×
FY 2014 5y median 2.8× FY 2023
P/FCF -34.4×
FY 2014 5y median -6.5× FY 2023
EV/EBITDA -28.2×
FY 2014 5y median -1.9× FY 2023
EV/Sales 77.8×
FY 2014 5y median 0.0× FY 2023
FCF Yield -2.9%
FY 2014 5y median -15.3% FY 2023
Profitability
Gross Margin 97.8%
FY 2014 5y median 0.0% FY 2023
Operating Margin -327.2%
FY 2014 5y median 0.0% FY 2023
Net Margin -339.1%
FY 2014 5y median 0.0% FY 2023
ROE -36.1%
FY 2014 5y median -54.9% FY 2023
ROIC -24.9%
FY 2014 5y median -47.5% FY 2023
ROA -24.2%
FY 2014 5y median -45.8% FY 2023
Growth (YoY)
Revenue 0.0%
FY 2014 FY 2023
Operating Income -9.2%
FY 2014 FY 2023
EPS (diluted) 26.7%
FY 2014 FY 2023
Free Cash Flow 13.4%
FY 2014 FY 2023
Financial Health
Current Ratio 11.0×
FY 2014 5y median 11.0× FY 2023
Quick Ratio 11.0×
FY 2014 5y median 11.0× FY 2023
Debt / Equity 0.4×
FY 2014 5y median 0.4× FY 2023
Net Debt / EBITDA 1.1×
FY 2014 5y median -0.8× FY 2023
Interest Coverage -5.4×
FY 2014 5y median -5.4× FY 2023
Dividends
Dividend Yield 0.0%
FY 2014 5y median 0.0% FY 2023
Payout Ratio 0.0%
FY 2014 5y median 0.0% FY 2023
Annual · latest fiscal year ends 2023-12-31